GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: VX-853 | VX853
Compound class:
Synthetic organic
Comment: Timcodar (VX-853) is a pyridine compound that was developed by Vertex Pharmaceuticals. It acts as a mammalian and bacterial efflux pump inhibitor. It was proposed to enhance activity of antibacterials such as rifampin, by inhibiting their efflux via bacterial efflux pumps [1,3]. It was also investigated for potential to prevent efflux of chemotherapy drugs, to enhance cancer treatment, and has been proposed as a possible antiobesity therapy [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (2S)-N-benzyl-3-(4-chlorophenyl)-N-(1,5-dipyridin-4-ylpentan-3-yl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]propanamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7807 | timcodar |
Synonyms ![]() |
| VX-853 | VX853 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Timcodar |
| Other databases | |
| BindingDB Ligand | 50388313 |
| CAS Registry No. | 179033-51-3 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL2059028 |
| DrugBank Ligand | DB12761 |
| GtoPdb PubChem SID | 405560309 |
| PubChem CID | 9811664 |
| Search Google for chemical match using the InChIKey | MQSMWZHHUGSULF-QNGWXLTQSA-N |
| Search Google for chemicals with the same backbone | MQSMWZHHUGSULF |
| Search PubMed clinical trials | timcodar |
| Search PubMed titles | timcodar |
| Search PubMed titles/abstracts | timcodar |
| UniChem Compound Search for chemical match using the InChIKey | MQSMWZHHUGSULF-QNGWXLTQSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MQSMWZHHUGSULF-QNGWXLTQSA-N |